Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 5, Pages 1199
Publisher
MDPI AG
Online
2020-05-12
DOI
10.3390/cancers12051199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway
- (2018) Dawei Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Re-expression of microRNA-4319 inhibits growth of prostate cancer via Her-2 suppression
- (2018) X. Lin et al. Clinical & Translational Oncology
- Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients
- (2018) Shanthi Sabarimurugan et al. Molecular Diagnosis & Therapy
- Letter to the Editor in response to the article, “The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis”
- (2018) Rama Jayaraj et al. ORAL ONCOLOGY
- Systematic review and meta-analysis of risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: Approaches and strategies
- (2018) Rama Jayaraj et al. ORAL ONCOLOGY
- Head and neck cancer risk factors in India: protocol for systematic review and meta-analysis
- (2018) Aayush Poddar et al. BMJ Open
- Letter to the editor “Prognostic value of microRNAs in colorectal cancer: a meta-analysis”
- (2018) Rama Jayaraj et al. Cancer Management and Research
- Comment on “Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer”
- (2018) Rama Jayaraj et al. DISEASE MARKERS
- Epidemiologic analysis of breast cancer incidence, prevalence, and mortality in India
- (2018) Madurantakam Royam Madhav et al. MEDICINE
- Systematic review and meta-analysis of cancer studies evaluating diagnostic test accuracy and prognostic values: approaches to improve clinical interpretation of results
- (2018) Rama Jayaraj et al. Cancer Management and Research
- TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer
- (2017) M K Siu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy
- (2017) Ricardo Leão et al. UROLOGIA INTERNATIONALIS
- Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling
- (2017) Jian-zhou Liu et al. UROLOGY
- MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1
- (2017) Lei Chen et al. WORLD JOURNAL OF UROLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia
- (2016) Blánaid M Hicks et al. THORAX
- Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer
- (2015) Y. Yang et al. CLINICAL CANCER RESEARCH
- Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer
- (2015) HAIQIU LIAO et al. ONCOLOGY REPORTS
- MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer
- (2015) Ying-chun Gao et al. TUMOR BIOLOGY
- VEGF-activated miR-144 regulates autophagic survival of prostate cancer cells against Cisplatin
- (2015) Feng Liu et al. TUMOR BIOLOGY
- Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel
- (2015) Ewa Kopczyńska Wspolczesna Onkologia-Contemporary Oncology
- MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer
- (2015) Wei-Yu Chen et al. Oncotarget
- Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
- (2014) H-M Lin et al. BRITISH JOURNAL OF CANCER
- MicroRNAs and Drug Resistance in Prostate Cancers
- (2014) Feng Li et al. MOLECULAR PHARMACEUTICS
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31
- (2014) Q Zhang et al. Cell Death & Disease
- Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer
- (2013) Yuji Toiyama et al. ANNALS OF SURGERY
- Circulating microRNAs as potential new biomarkers for prostate cancer
- (2013) A Sita-Lumsden et al. BRITISH JOURNAL OF CANCER
- Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical Cancer
- (2013) Shan Zhao et al. Genetic Testing and Molecular Biomarkers
- 2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial
- (2013) Pirkko-Liisa Kellokumpu-Lehtinen et al. LANCET ONCOLOGY
- miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1
- (2013) JUNJIE YU et al. ONCOLOGY REPORTS
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling
- (2012) Y.-C. Lu et al. Cancer Prevention Research
- Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
- (2012) Haiyan Si et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
- (2012) Manuel Valladares-Ayerbes et al. Journal of Translational Medicine
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer
- (2012) S-F Su et al. ONCOGENE
- Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway
- (2012) Saurabh Singh et al. PLoS One
- Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
- (2012) Xi Zeng et al. PLoS One
- Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
- (2012) Sandeep Sheth et al. PLoS One
- Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer
- (2012) Han Christine Ngoc Nguyen et al. PROSTATE
- The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers
- (2012) Weijie Chen et al. TUMOR BIOLOGY
- The role of EZH2 in tumour progression
- (2011) C-J Chang et al. BRITISH JOURNAL OF CANCER
- Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
- (2011) P. Ostling et al. CANCER RESEARCH
- MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2
- (2011) J. Lu et al. CANCER RESEARCH
- MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer
- (2011) Seong O. Suh et al. CARCINOGENESIS
- MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
- (2011) M. Preis et al. CLINICAL CANCER RESEARCH
- Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
- (2011) R. Liu et al. CLINICAL CHEMISTRY
- High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
- (2011) Xiao-Guang Liu et al. MEDICAL ONCOLOGY
- miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
- (2011) Bin Xu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer
- (2011) Juan Wei et al. Chinese Journal of Cancer
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
- (2010) Shihua Sun et al. JOURNAL OF CLINICAL INVESTIGATION
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Cytotoxic Effects Induced by Docetaxel, Gefitinib, and Cyclopamine on Side Population and Nonside Population Cell Fractions from Human Invasive Prostate Cancer Cells
- (2010) M. Mimeault et al. MOLECULAR CANCER THERAPEUTICS
- Drug resistance in metastatic castration-resistant prostate cancer
- (2010) Bostjan Seruga et al. Nature Reviews Clinical Oncology
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
- (2010) Jin-Hyeok Hwang et al. PLoS One
- Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy
- (2010) Hai-Liang Zhang et al. PROSTATE
- miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
- (2009) J. Ribas et al. CANCER RESEARCH
- MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC
- (2009) Takashi Sasayama et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance
- (2008) S. M. Dehm et al. CANCER RESEARCH
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- A genome-wide RNAi screen for Wnt/ -catenin pathway components identifies unexpected roles for TCF transcription factors in cancer
- (2008) W. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now